Neuroendocrine modulation of cancer progression

被引：100

作者：

Armaiz-Pena, Guillermo N. ^{[1
,3
]}

Lutgendorf, Susan K. ^{[4
,5
,6
]}

Cole, Steve W. ^{[7
]}

Sood, Anil K. ^{[1
,2
]}

机构：

[1] Univ Texas MD Anderson Canc Ctr, Dept Gynecol Oncol, Houston, TX 77030 USA

[2] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA

[3] Univ Texas Houston, Hlth Sci Ctr, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX USA

[4] Univ Iowa, Dept Psychol, Iowa City, IA 52242 USA

[5] Univ Iowa, Dept Obstet & Gynecol, Iowa City, IA 52242 USA

[6] Univ Iowa, Dept Urol, Iowa City, IA 52242 USA

[7] Univ Calif Los Angeles, Sch Med, Dept Med, Div Hematol Oncol, Los Angeles, CA 90024 USA

来源：

BRAIN BEHAVIOR AND IMMUNITY | 2009年 / 23卷 / 01期

关键词：

Cancer; Behavioral stress; Angiogenesis; Metastasis; ENDOTHELIAL GROWTH-FACTOR; BETA-ADRENERGIC-RECEPTORS; OVARIAN-CARCINOMA CELLS; STRESSFUL LIFE EVENTS; BREAST-CANCER; PSYCHOSOCIAL FACTORS; NEUROBLASTOMA-CELLS; TUMOR-GROWTH; SUBSTANCE-P; RISK;

D O I：

10.1016/j.bbi.2008.06.007

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Clinical and animal studies now support the notion that psychological factors such as stress, chronic depression, and lack of social support might promote tumor growth and progression. Recently, cellular and molecular studies have started to identify biological processes that could mediate such effects. This review provides a mechanistic understanding of the relationship between biological and behavioral influences in cancer and points to more comprehensive behavioral and pharmacological approaches for better patient outcomes. (c) 2008 Elsevier Inc. All rights reserved.

引用

页码：10 / 15

页数：6

共 44 条

[1] Opinion - The influence of bio-behavioural factors on tumour biology: pathways and mechanisms
Antoni, MH
Lutgendorf, SK
Cole, SW
Dhabhar, FS
Sephton, SE
McDonald, PG
Stefanek, M
Sood, AK
[J]. NATURE REVIEWS CANCER, 2006, 6 (03) : 240 - 248
[2] The neurotransmitter dopamine inhibits angiogenesis induced by vascular permeability factor/vascular endothelial growth factor
Basu, S
Nagy, JA
Pal, S
Vasile, E
Eckelhoefer, IA
Bliss, VS
Manseau, EJ
Dasgupta, PS
Dvorak, HF
Mukhopadhyay, D
[J]. NATURE MEDICINE, 2001, 7 (05) : 569 - 574
[3] Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland
Bissell, M. J.
[J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 2007, 35 : 18 - 22
[4] Personality factors and breast cancer risk: A 13-year follow-up
Bleiker, Eveline M. A.
Hendriks, Jan H. C. L.
Otten, Johannes D. M.
Verbeek, Andre L. M.
van der Ploeg, Henk M.
[J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2008, 100 (03): : 213 - 218
[5] Epac proteins: multi-purpose cAMP targets
Bos, Johannes L.
[J]. TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (12) : 680 - 686
[6] A chemical biology approach identifies a beta-2 adrenergic receptor agonist that causes human tumor regression by blocking the Raf-1/Mek-1/Erk1/2 pathway
Carie, A. E.
Sebti, S. M.
[J]. ONCOGENE, 2007, 26 (26) : 3777 - 3788
[7] Biological relevance of oxytocin and oxytocin receptors in cancer cells and primary tumors
Cassoni, P
Marrocco, T
Deaglio, S
Sapino, A
Bussolati, G
[J]. ANNALS OF ONCOLOGY, 2001, 12 : S37 - S39
[8] Dopaminergic and adrenergic toxicities on SK-N-MC human neuroblastoma cells are mediated through G protein signaling and oxidative stress
Chan, Anthony S. L.
Ng, Linda W. C.
Poon, Lydia S. W.
Chan, Winnie W. Y.
Wong, Yung H.
[J]. APOPTOSIS, 2007, 12 (01) : 167 - 179
[9] NEUROENDOCRINE CELLS - A NEW PROGNOSTIC PARAMETER IN PROSTATE-CANCER
COHEN, RJ
GLEZERSON, G
HAFFEJEE, Z
[J]. BRITISH JOURNAL OF UROLOGY, 1991, 68 (03): : 258 - 262
[10] Psychosocial factors and interleukin-6 among women with advanced ovarian cancer
Costanzo, ES
Lutgendorf, SK
Sood, AK
Anderson, B
Sorosky, J
Lubaroff, DM
[J]. CANCER, 2005, 104 (02) : 305 - 313

← 1 2 3 4 5 →